VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM
- Status
- UNKNOWN
- Phase
- PHASE2
Autologous Transplantation for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
EMMA-1 (Erbitux for Multiple Myeloma)
- Status
- TERMINATED
- Phase
- PHASE2
Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Agriculture Health Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation
- Status
- COMPLETED
- Phase
- PHASE4
High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
TCD Followed by autoSCT for Newly Diagnosed MM Patients
- Status
- UNKNOWN
- Phase
- PHASE2